WallStreetZenWallStreetZen

NASDAQ: AGRX
Agile Therapeutics Inc Stock

Open Broker Account
$0.28+0.00 (+0%)
Updated Sep 27, 2022
AGRX Price
$0.28
Fair Value Price
$3.17
Market Cap
$11.08M
52 Week Low
$0.26
52 Week High
$41.20
P/E
-0.01x
P/B
3.24x
P/S
0.79x
PEG
N/A
Dividend Yield
N/A
Revenue
$6.69M
Earnings
-$64.12M
Gross Margin
-82%
Operating Margin
-973.36%
Profit Margin
-958.7%
Debt to Equity
8.6
Operating Cash Flow
-$53M
Beta
1
Next Earnings
Oct 31, 2022
Ex-Dividend
N/A
Next Dividend
N/A

AGRX Overview

Zen Score

Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AGRX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AGRX ($0.28) is undervalued by 91.05% relative to our estimate of its Fair Value price of $3.17 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
AGRX ($0.28) is significantly undervalued by 91.05% relative to our estimate of its Fair Value price of $3.17 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
AGRX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more AGRX due diligence checks available for Premium users.

Be the first to know about important AGRX news, forecast changes, insider trades & much more!

AGRX News

Valuation

AGRX fair value

Fair Value of AGRX stock based on Discounted Cash Flow (DCF)
Price
$0.28
Fair Value
$3.17
Undervalued by
91.18%
AGRX ($0.28) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
AGRX ($0.28) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
AGRX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

AGRX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.01x
Industry
20.12x
Market
28.09x

AGRX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.24x
Industry
1.68x
AGRX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

AGRX's financial health

Profit margin

Revenue
$2.1M
Net Income
-$12.2M
Profit Margin
-574.7%
AGRX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
AGRX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$32.8M
Liabilities
$29.4M
Debt to equity
8.6
AGRX's short-term liabilities ($28.78M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AGRX's short-term assets ($18.47M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AGRX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
AGRX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.9M
Investing
-$7.0k
Financing
$12.2M
AGRX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

AGRX vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
AGRX$11.08M0.00%-0.01x3.24x
NEPT$11.67M+6.57%-0.11x0.27x
PTPI$10.34M0.00%-0.49x0.30x
HAPP$12.66M+9.59%-0.13x0.16x
SISI$8.96M+1.72%-0.27x0.22x

Agile Therapeutics Stock FAQ

What is Agile Therapeutics's quote symbol?

NASDAQ: AGRX) Agile Therapeutics trades on the NASDAQ under the ticker symbol AGRX. Agile Therapeutics stock quotes can also be displayed as NASDAQ: AGRX.

If you're new to stock investing, here's how to buy Agile Therapeutics stock.

What is the 52 week high and low for Agile Therapeutics (NASDAQ: AGRX)?

(NASDAQ: AGRX) Agile Therapeutics's 52-week high was $41.20, and its 52-week low was $0.26. It is currently -99.31% from its 52-week high and 8.4% from its 52-week low.

How much is Agile Therapeutics stock worth today?

(NASDAQ: AGRX) Agile Therapeutics currently has 39,023,023 outstanding shares. With Agile Therapeutics stock trading at $0.28 per share, the total value of Agile Therapeutics stock (market capitalization) is $11.08M.

Agile Therapeutics stock was originally listed at a price of $221.60 in May 23, 2014. If you had invested in Agile Therapeutics stock at $221.60, your return over the last 8 years would have been -99.87%, for an annualized return of -56.5% (not including any dividends or dividend reinvestments).

How much is Agile Therapeutics's stock price per share?

(NASDAQ: AGRX) Agile Therapeutics stock price per share is $0.28 today (as of Sep 27, 2022).

What is Agile Therapeutics's Market Cap?

(NASDAQ: AGRX) Agile Therapeutics's market cap is $11.08M, as of Sep 28, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Agile Therapeutics's market cap is calculated by multiplying AGRX's current stock price of $0.28 by AGRX's total outstanding shares of 39,023,023.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.